Domov › Rak dojke › Kalifornija › Baldwin Park
Klinične študije za Rak dojke v Baldwin Park, CA
44 študij za Rak dojke išče udeležence na lokacijah v Baldwin Park in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Vključevanje udeležencevFaza 3
- City of Hope National Medical Center, Duarte · 4 mi stran
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Vključevanje udeležencevFaza 2
- City of Hope - Duarte Cancer Center, Duarte · 4 mi stran
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Vključevanje udeležencevFaza 3
- City of Hope National Medical, Duarte · 4 mi stran
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- City of Hope, Duarte · 4 mi stran
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi stran
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Vključevanje udeležencevFaza 1
- Research Site, Duarte · 4 mi stran
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Vključevanje udeležencevFaza 2
- City of Hope, Duarte · 4 mi stran
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- City of Hope, Duarte · 4 mi stran
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Vključevanje udeležencevFaza 2
- City of Hope, Duarte · 4 mi stran
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Vključevanje udeležencevFaza 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi stran
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Vključevanje udeležencevFaza 1/2
- City of Hope, Duarte · 4 mi stran
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Vključevanje udeležencevFaza 3
- City of Hope National Medical Center, Duarte · 4 mi stran
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Vključevanje udeležencevFaza 1/2
- City of Hope - Duarte, Duarte · 4 mi stran
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Vključevanje udeležencevFaza 3
- Research Site, Duarte · 4 mi stran
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Vključevanje udeležencevFaza 1/2
- City of Hope, Duarte · 4 mi stran
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Vključevanje udeležencevFaza 1/2
- City of Hope, Duarte · 4 mi stran
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- City of Hope Medical Center, Duarte · 4 mi stran
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Vključevanje udeležencevFaza 2
- City of Hope--Duarte, Duarte · 4 mi stran
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Vključevanje udeležencev
- City of Hope Medical Center, Duarte · 4 mi stran
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Vključevanje udeležencevFaza 3
- City of Hope - Duarte Cancer Center, Duarte · 4 mi stran
E-Mindfulness Approaches for Living After Breast Cancer
Vključevanje udeležencevFaza 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi stran
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Vključevanje udeležencevFaza 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi stran
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
Vključevanje udeležencevFaza 4
- City of Hope Medical Center, Duarte · 4 mi stran
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- City of Hope Medical Center, Duarte · 4 mi stran
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Vključevanje udeležencevFaza 3
- City of Hope Medical Center, Duarte · 4 mi stran
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Vključevanje udeležencevFaza 2
- City of Hope, Duarte · 4 mi stran
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Vključevanje udeležencev
- Beckman Research Institute of City of Hope, Duarte · 4 mi stran
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- City of Hope, Duarte · 4 mi stran
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- City of Hope, Duarte · 4 mi stran
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- City of Hope Medical Center, Duarte · 4 mi stran
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Duarte · 4 mi stran
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Vključevanje udeležencevFaza 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi stran
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
Vključevanje udeležencevFaza 2
- City of Hope Medical Center, Duarte · 4 mi stran
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
Vključevanje udeležencevFaza 1
- City of Hope Medical Center, Duarte · 4 mi stran
Študije za Rak dojke v drugih mestih
- New York City, NY136 študij
- Houston, TX126 študij
- Boston, MA112 študij
- Nashville, TN81 študij
- Los Angeles, CA73 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Queens, NY64 študij
- Durham, NC64 študij
- Chicago, IL59 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
Druge študije v Baldwin Park
- Akutna mieločna levkemija40 študij
- Kolorektalni rak37 študij
- Nemalicelični pljučni rak36 študij
- Rak (vse vrste)34 študij
- Rak prostate30 študij
- Metastatski rak30 študij
- Mielodisplastični sindromi26 študij
- Rak jajčnikov25 študij
- Rak pljuč24 študij
- Množni mielom23 študij
- Rak želodca22 študij
- Akutna limfoblastna levkemija21 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.